Log in

Relevant bibliographies by topics / Primary Central Nervous System (CNS) Lymphoma

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Primary Central Nervous System (CNS) Lymphoma'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Primary Central Nervous System (CNS) Lymphoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Bednar, Martin M., Anthony Salerni, Martin E. Flanagan, and William W. Pendlebury. "Primary central nervous system T-cell lymphoma." Journal of Neurosurgery 74, no. 4 (1991): 668–72. http://dx.doi.org/10.3171/jns.1991.74.4.0668.

Full text

Abstract:

✓ Primary central nervous system (CNS) T-cell lymphoma is extremely rare. The present case report provides immunocytochemical evidence for a cerebellar CNS T-cell lymphoma. The patient underwent surgery followed by radiation therapy and is alive and well 36 months postoperatively. The clinical and pathological features of primary CNS T-cell lymphoma as well as diagnostic measures and treatment options are discussed, together with a compilation of all previous case reports of primary CNS T-cell lymphomas.

APA, Harvard, Vancouver, ISO, and other styles

2

Schaff, Lauren. "Central Nervous System Lymphoma." CONTINUUM: Lifelong Learning in Neurology 29, no. 6 (2023): 1710–26. http://dx.doi.org/10.1212/con.0000000000001356.

Full text

Abstract:

ABSTRACT OBJECTIVE This article reviews the clinical presentation, diagnostic workup, staging, and treatment of primary central nervous system (CNS) lymphoma and common manifestations of secondary CNS lymphoma. LATEST DEVELOPMENTS Lymphoma can arise in the CNS de novo (primary CNS lymphoma) or as the result of systemic disease (secondary CNS lymphoma). Symptoms may include focal neurologic deficits related to the disease site, cognitive decline, and symptoms of increased intracranial pressure. Standard treatment may differ based on lymphoma subtype and location. A majority of CNS lymphoma is d

APA, Harvard, Vancouver, ISO, and other styles

3

Kadoch, Cigall, Patrick Treseler, and James L. Rubenstein. "Molecular pathogenesis of primary central nervous system lymphoma." Neurosurgical Focus 21, no. 5 (2006): 1–5. http://dx.doi.org/10.3171/foc.2006.21.5.2.

Full text

Abstract:

✓ Primary central nervous system lymphoma (PCNSL) is an aggressive form of non-Hodgkin lymphoma (NHL) typically associated with a worse prognosis than other localized extranodal lymphomas with similar histological characteristics. The defining feature of PCNSL is its confinement to the central nervous system (CNS), with proclivity for growth within the leptomeningeal as well as intraocular compartments. Primary CNS lymphoma rarely disseminates outside the CNS and accounts for less than 5% of all primary brain neoplasms. At least 95% of PCNSLs are of large B-cell histology, the most common subt

APA, Harvard, Vancouver, ISO, and other styles

4

Hochberg, Fred H., and Douglas C. Miller. "Primary central nervous system lymphoma." Journal of Neurosurgery 68, no. 6 (1988): 835–53. http://dx.doi.org/10.3171/jns.1988.68.6.0835.

Full text

Abstract:

✓ Primary lymphoma of the central nervous system (CNS), including reticulum cell sarcoma, microglioma, and histiocytic lymphoma, represents less than 1% of all primary brain tumors. In the last 10 years, this tumor has tripled in frequency in the nonimmunosuppressed population. By 1991, the tumor will be the most common neurological neoplasm by virtue of the increase in sporadic occurrence and in the acquired immunodeficiency syndrome (AIDS) population. Three percent of AIDS patients will develop this tumor either prior to AIDS diagnosis or during their subsequent course. In addition to acquir

APA, Harvard, Vancouver, ISO, and other styles

5

Kawakami, Yasuto, Kazuo Tabuchi, Rinkichi Ohnishi, Shoji Asari, and Akira Nishimoto. "Primary central nervous system lymphoma." Journal of Neurosurgery 62, no. 4 (1985): 522–27. http://dx.doi.org/10.3171/jns.1985.62.4.0522.

Full text

Abstract:

✓ A retrospective analysis of 21 cases of primary central nervous system (CNS) lymphoma is reported. All patients presented with a solitary mass in the supratentorial region. None had previously received immunosuppressive therapy. Neuroradiological studies included technetium-99m-pertechnetate brain scanning in eight cases, cerebral arteriography in all 21 cases, and computerized tomography (CT) in 14 cases. The characteristic features were increased uptake in brain scans, mass effect in arteriograms, and marked contrast enhancement on CT scans. Abnormal tumor vessels were occasionally seen on

APA, Harvard, Vancouver, ISO, and other styles

6

Kwok, Hoi Ming, Kwok Yan Li, Rois L. S. Chan, et al. "Different facets of intracranial central nervous system lymphoma and its imaging mimics." Journal of Clinical Imaging Science 12 (February 4, 2022): 4. http://dx.doi.org/10.25259/jcis_135_2021.

Full text

Abstract:

Lymphomas of the central nervous system (CNS) are broadly classified into primary CNS lymphoma (PCNSL) and secondary CNS lymphoma (SCNSL). PCNSL refers to lymphoma restricted to the brain, leptomeninges, spinal cord, or eyes without evidence of it outside the CNS at primary diagnosis, while SCNSL refers to secondary CNS involvement by systemic lymphoma. The brain is the most common site of involvement and intracranial CNS lymphoma has a highly variable imaging appearance and varies according to the patient’s clinical profile and immunity. This pictorial essay aims to illustrate the different f

APA, Harvard, Vancouver, ISO, and other styles

7

Forde, P., C. Grant, E. Smith, et al. "Primary central nervous system lymphoma: An Irish clinical experience." Journal of Clinical Oncology 27, no. 15_suppl (2009): e13032-e13032. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e13032.

Full text

Abstract:

e13032 Background: North American studies have demonstrated an increase in incidence of primary CNS lymphoma in recent decades. To our knowledge there have been no studies analyzing primary CNS lymphoma in the Irish setting. This prompted a review of cases diagnosed at our institution, the larger of two national neurosurgical/neuro-oncology referral centers. Methods: The records of 78 patients diagnosed with primary CNS lymphoma at our institution between January 1999 and October 2008 were reviewed. Patient's age, sex, and time to diagnosis were noted. Histology and radiology was reviewed for

APA, Harvard, Vancouver, ISO, and other styles

8

Ferreri, Andrés J. M., Matthias Holdhoff, Lakshmi Nayak, and James L. Rubenstein. "Evolving Treatments for Primary Central Nervous System Lymphoma." American Society of Clinical Oncology Educational Book, no. 39 (May 2019): 454–66. http://dx.doi.org/10.1200/edbk_242547.

Full text

Abstract:

Primary central nervous system (CNS) lymphoma (PCNSL) is an aggressive form of non-Hodgkin lymphoma that remains confined to the CNS neuroaxis during its natural history of disease and is therefore considered stage IE disease. PCNSL is diffuse large B-cell lymphoma (DLBCL) morphology in more than 95% of patients and is designated primary diffuse large B-cell lymphoma of the CNS on the basis of the 2017 World Health Organization classification of hematopoietic and lymphoid tumors. Rapidly evolving therapeutic paradigms have been linked to evidence of progress in PCNSL, a disease long considered

APA, Harvard, Vancouver, ISO, and other styles

9

Tun, Han W., David Personett, Karen A. Baskerville, et al. "Pathway analysis of primary central nervous system lymphoma." Blood 111, no. 6 (2008): 3200–3210. http://dx.doi.org/10.1182/blood-2007-10-119099.

Full text

Abstract:

Abstract Primary central nervous system (CNS) lymphoma (PCNSL) is a diffuse large B-cell lymphoma (DLBCL) confined to the CNS. A genome-wide gene expression comparison between PCNSL and non-CNS DLBCL was performed, the latter consisting of both nodal and extranodal DLBCL (nDLBCL and enDLBCL), to identify a “CNS signature.” Pathway analysis with the program SigPathway revealed that PCNSL is characterized notably by significant differential expression of multiple extracellular matrix (ECM) and adhesion-related pathways. The most significantly up-regulated gene is the ECM-related osteopontin (SPP

APA, Harvard, Vancouver, ISO, and other styles

10

Sobrevilla-Moreno, Nora, Marcela Janka-Zires, Pedro Sobrevilla-Calvo, Luis Durazo-Cons, and Silvia Rivas-Vera. "Central Nervous System Involvement in Primary Nasal Lymphoma." Blood 114, no. 22 (2009): 2940. http://dx.doi.org/10.1182/blood.v114.22.2940.2940.

Full text

Abstract:

Abstract Abstract 2940 Poster Board II-916 Introduction. Nasal NK/T cell lymphoma (NNK/TCL) is a tumor with a low prevalence but is more frequent in Asia and South America. There is no standard treatment for these patients, although radiotherapy is usually recommended. Few reports describe the frequency of central nervous system (CNS) involvement in this type of lymphoma and, in consequence, little is known about the benefit of carrying out screening procedures such as cerebrospinal fluid (CSF) cytology or image studies, nor it is known if prophylactic radiotherapy to the CNS or intrathecal ch

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Kishimoto, Wataru. "Expression of Tim-1 in primary CNS lymphoma." 京都大学 (Kyoto University), 2017. http://hdl.handle.net/2433/225485.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Schob, Stefan, Jonas Meyer, Matthias Gawlitza, et al. "Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma." Universitätsbibliothek Leipzig, 2016. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-210909.

Full text

Abstract:

Purpose: To investigate if apparent diffusion coefficient (ADC) values within primary central nervous system lymphoma correlate with cellularity and proliferative activity in corresponding histological samples. Materials and Methods: Echo-planar diffusion-weighted magnetic resonance images obtained from 21 patients with primary central nervous system lymphoma were reviewed retrospectively. Regions of interest were drawn on ADC maps corresponding to the contrast enhancing parts of the tumors. Biopsies from all 21 patients were histologically analyzed. Nuclei count, total nuclei area and average

APA, Harvard, Vancouver, ISO, and other styles

3

Kuitunen, H. (Hanne). "DLBCL, primary and secondary central nervous system involvement, treatment and prophylaxis." Doctoral thesis, Oulun yliopisto, 2017. http://urn.fi/urn:isbn:9789526217154.

Full text

Abstract:

Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common type of Non-Hodgkin´s Lymphoma (NHL). The standard treatment for DLBCL is R-CHOP chemoimmunotherapy (rituximab, cyclophosphamide, vincristine, doxorubicin and prednisone). About one -third of patients have refractory disease or the lymphoma relapses. Prognosis after relapse of refractory disease is poor. Fitter and younger patients are recommended new intensive salvage chemotherapy followed by autologous stem cell transplantation. Central nervous system (CNS) relapse is the most feared complication with dismal prognosis in DLBCL

APA, Harvard, Vancouver, ISO, and other styles

4

Li, Xinwei [Verfasser]. "The Expression of MGMT and Ku80 in Primary Central Nervous System Lymphoma and Prognostic Significance / Xinwei Li." Kiel : Universitätsbibliothek Kiel, 2015. http://d-nb.info/1067842128/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nakajima, Satoshi. "Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography." Kyoto University, 2016. http://hdl.handle.net/2433/204580.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Simmons, William Minnow. "Contributions of viral and cellular gene products to the pathogenesis and prognosis of aggressive lymphomas." Thesis, University of Wolverhampton, 2016. http://hdl.handle.net/2436/609034.

Full text

Abstract:

High grade aggressive lymphomas have high mortality. By their nature, more than 40% of patients die from these diseases even with the improved treatment strategies currently available for oncology patients. The characteristic feature is that they are functionally heterogeneous and therefore have different biological and molecular signatures which make it difficult for all groups to respond to same line of treatment. Based on the above, I set out to look at the impact of viral and cellular gene products on these groups of diseases: In chapter 3 I developed monoclonal antibodies against HERV‐K10

APA, Harvard, Vancouver, ISO, and other styles

7

Szvetko, Attila Laszlo. "Gene Expression and Variation in Multiple Sclerosis." Thesis, Griffith University, 2009. http://hdl.handle.net/10072/366285.

Full text

Abstract:

Neurological diseases are complex and difficult diseases to study. Although new approaches and therapies have been developed for other disorders such as Alzheimer’s, Epilepsy, and Parkinson’s disease, Multiple Sclerosis (MS) still remains seemingly inexorable. MS is the archetypal complex disease; it is a paradigm of debilitating neuropathology. Discounting trauma, MS is the most common chronic neurological condition resulting in disability affecting young adults. In its typical form it primarily affects the brain, spinal cord, and optic nerves and is characterised by lesions in the central ne

APA, Harvard, Vancouver, ISO, and other styles

8

Malesz, Alexandra Elizabeth. "Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study." Thesis, 2016. https://hdl.handle.net/2144/19487.

Full text

Abstract:

OBJECTIVE: The aim of this study was to investigate the safety and tolerability of a novel anti-folate drug, pemetrexed, in the setting of a phase I clinical trial in patients with non-HIV related central nervous system lymphoma (CNSL). METHODS: In this multicenter, open-label, phase I dose finding clinical trial, pemetrexed was investigated as a single agent treatment for primary or secondary CNSL. RESULTS: A total of 18 patients were enrolled between January 2009 and November 2014. The mean age was 64.6 years old (range: 47-79). The ratio of male to female was 1:1. One out of six patients

APA, Harvard, Vancouver, ISO, and other styles

9

Lin, Ching-Hung, and 林璟宏. "Study of Primary Central Nervous System Lymphoma." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/07215879855137135266.

Full text

Abstract:

碩士<br>國立臺灣大學<br>臨床醫學研究所<br>93<br>Comparison of the Expression and Prognostic Significance of Differentiation Markers between Diffuse Large B-Cell Lymphoma of Central Nervous System Origin and Peripheral Nodal Origin Purpose: Whether diffuse large B-cell lymphoma (DLBCL) of primary central nervous system origin (PCNSL) is biologically different from DLBCL of peripheral nodal origin (NL) remains unclear. The purpose of this study was to compare the expression frequency and prognostic significance of a panel of cell differentiation markers between these two disease entities. Experimental design:

APA, Harvard, Vancouver, ISO, and other styles

10

Münch, Benno Jürgen Helmut. "Whole Tumor Histogramm-profiling of Diffusion-Weighted Magnetic Resonance Images reflects tumorbiological features of Primary Central Nervous System Lymphoma." 2018. https://ul.qucosa.de/id/qucosa%3A34107.

Full text

Abstract:

Das Ziel der vorliegenden Arbeit war die Untersuchung des Zusammenhangs zwischen Parametern in der bildgebenden Diagnostik mittels Diffusion-Weighted Imaging und histopathologischen Eigenschaften von primären Lymphomen des zentralen Nervensystems. Hierzu wurden die bioptischen Resektate von 21 Patient*innen mit der gesicherten Diagnose eines primären Lymphoms des zentralen Nervensystems neuropathologisch untersucht. Es wurden der Ki-67 Index, die Zellzahl und das durchschnittliche sowie gesamte Zellkern-Areal bestimmt. In der bildgebenden Diagnostik erfolgte die Untersuchung der MRT Bildge

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Maiuri, Francesco. Primary lymphomas of the central nervous system. Editoriale BIOS, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Diaz, Roberto Jose, Gregory W. Basil, and Ricardo J. Komotar. Primary CNS Lymphoma. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0008.

Full text

Abstract:

Central nervous system (CNS) lymphoma must be considered in the differential diagnosis of any immunocompromised patient with a solid brain lesion. In such patients, diagnosis can be made via a careful review of important signs, symptoms, and classic radiologic findings. While there is no single physical exam finding classic for lymphoma, the clinician must carefully evaluate patients for the presence or absence of findings that may suggest an alternative diagnosis. Such findings include the stigmata of endocarditis, symptoms suggestive of pneumonia, or additional non-CNS mass lesions. Addition

APA, Harvard, Vancouver, ISO, and other styles

3

Batchelor, Tracy T., Oussama Abla, Zhong-ping Chen, Dennis C. Shrieve, and Samar Issa. Tumours of the haematopoietic system. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0013.

Full text

Abstract:

‘Tumours of the haematopoietic system’ examines the epidemiology, the pathogenesis, and the clinical features of adult and childhood primary central nervous system lymphomas (PCNSLs), extranodal forms of non-Hodgkin lymphoma, as well as the histiocytoses included in the World Health Organization (WHO) classification of central nervous system (CNS) tumours. It reviews these features in the most common PCNSL, primary central nervous system diffuse large B-cell lymphoma, as well as the other rare histopathological PCNSL variants including lymphomatoid granulomatosis, T-cell lymphoma, anaplastic l

APA, Harvard, Vancouver, ISO, and other styles

4

DeAngelis, Lisa M. Primary Central Nervous System Lymphoma. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0133.

Full text

Abstract:

The lymphoid nature of PCNSL was established unequivocally by modern immunohistochemical techniques. PCNSL has been associated with a variety of congenital (Wiskott-Aldrich syndrome, ataxia-telangiectasia) and acquired (human immunodeficiency virus [HIV], renal transplant recipients) immunodeficiency states. PCNSL tends to be supratentorial, periventricular, and involve the deep structures such as the basal ganglia. The Epstein-Barr virus (EBV) plays an important role in initiating the development of PCNSL in immunocompromised patients includinig those with HIV infection. Leukoencephalopathy i

APA, Harvard, Vancouver, ISO, and other styles

5

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Madhumita Bhattacharyya. Skin cancers. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0023_update_001.

Full text

Abstract:

Tumours of the central nervous system examines the epidemiology, aetiology, genetics and pathology of these heterogeneous tumours. Clinical presentation reflects the site of origin and rate of growth. Investigation usually comprises imaging (MRI superior to CT for most), and biopsy; requirement for additional staging depends on pathology. The treatment of low-grade gliomas may be delayed if small with few symptoms, otherwise surgery and/or radiotherapy. High grade gliomas may be managed with surgery, radiotherapy, and temozolomide chemotherapy in fit patients. Unfit patients should be offered

APA, Harvard, Vancouver, ISO, and other styles

6

Theeler, Brett J., and Mark R. Gilbert. Primary Central Nervous System Tumors. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0129.

Full text

Abstract:

Ependymomas are rare primary central nervous system (CNS) tumors that are thought to arise from ependymal cells lining the ventricular system located throughout the CNS. Ependymomas occur in all age groups but are more common in the pediatric population. Ependymomas typically present as mass lesions within the ventricular system, brain or spinal cord parenchyma. As with most central nervous system tumors, pathologic evaluation is required for definitive diagnosis. Ependymomas are typically treated with a combination of surgery and radiotherapy although this varies depending on tumor location,

APA, Harvard, Vancouver, ISO, and other styles

7

Yamanaka, Ryuya. Primary Central Nervous System Lymphoma: Incidence, Management and Outcomes. Nova Science Publishers, Incorporated, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

NCCN Guidelines for Patients® Primary Central Nervous System Lymphoma. National Comprehensive Cancer Network® (NCCN®), 2024.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Burnet, Neil G., Fiona Harris, Raj Jena, Kate E. Burton, and Sarah J. Jefferies. Central nervous system tumours. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199696567.003.0016.

Full text

Abstract:

Chapter 11 discusses central nervous system (CNS) tumours, including principles, planning volumes, dose distribution, high- and low-grade glioma, Ependymoma, Medulloblastoma, Germ cell tumours —germinoma and teratoma, Vestibular (acoustic) schwannoma, Pituitary tumours (including craniopharyngioma), Meningioma, and primary spinal cord tumours.

APA, Harvard, Vancouver, ISO, and other styles

10

Pagnoux, Christian, and Richard H. Swartz. Vasculitis of the Central Nervous System. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0099.

Full text

Abstract:

Central nervous system (CNS) vasculitis is an extremely challenging diagnostic and therapeutic disease. Multiple conditions, including reversible cerebral vasoconstrictive syndrome and intracranial atherosclerosis, can mimic it. Infections, systemic diseases, particularly systemic vasculitides, drug abuse, neoplasms, and some other disorders can cause secondary CNS vasculitis. Primary CNS vasculitis is extremely rare. A definite diagnosis requires a brain biopsy, which may show granulomatous inflammation, lymphocytic inflammation, and/or acute necrotizing vasculitis. The pathogeny remains unkn

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Milgrom, Sarah A., and Joachim Yahalom. "Primary Central Nervous System Lymphoma." In Adult CNS Radiation Oncology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-42878-9_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Imber, Brandon S., Kathryn R. Tringale, Sarah A. Milgrom, and Joachim Yahalom. "Primary Central Nervous System Lymphoma." In Adult CNS Radiation Oncology. Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-67878-3_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lacruz, César R., Agustín Acevedo, and Ricardo H. Bardales. "Primary CNS Lymphomas." In Central Nervous System Tumors. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-51078-6_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Otrock, Zaher K., and Ali Bazarbachi. "Paraneoplastic Syndromes in Primary CNS Lymphoma." In Tumors of the Central Nervous System, Volume 9. Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5488-1_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Trog, Daniela, and Andrea Baehr. "Radiation Therapy in Primary Central Nervous System (CNS) Lymphoma." In Radiation Oncology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-52619-5_28-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Richardson, Simon E., and Christopher McNamara. "Thiamine Deficiency Complicating the Treatment of Primary CNS Lymphoma." In Tumors of the Central Nervous System, Volume 9. Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5488-1_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Momota, Hiroyuki. "Primary CNS Lymphoma: Immunohistochemistry of BCL-6 and Treatment with High-Dose Methotrexate." In Tumors of the Central Nervous System, Volume 9. Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5488-1_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Boiardi, A., A. Silvani, A. Salmaggi, S. Valentini, A. Allegranza, and G. Broggi. "Chemotherapy as a first treatment for malignant primary CNS non-Hodgkin’s lymphoma of the central nervous system (PCNSL)." In Cancer Treatment An Update. Springer Paris, 1994. http://dx.doi.org/10.1007/978-2-8178-0765-2_125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lacruz, César R., and Eugenio Leonardo. "Primary CNS Melanocytic Neoplasms." In Central Nervous System Tumors. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-51078-6_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Abla, Oussama, Tracy T. Batchelor, and Andishe Attarbaschi. "Primary Central Nervous System Lymphoma." In Non-Hodgkin's Lymphoma in Childhood and Adolescence. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11769-6_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Caliari, Vitória de Ataide, Herika Negri, Claudio vidal, Bruno lobo, Dhyego lacerda, and Débora de Moura Muniz. "Primary Central Nervous System Lymphoma of the Posterior Fossa in Immunocompetent Patient: A Case Report and Review of Literature." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.025.

Full text

Abstract:

Context: Primary central nervous system lymphomas (PCNSL) are a rare but very aggressive subtype of extranodal non-Hodgkin lymphomas. They represent only 4% of primary central nervous system lesions and are more common in patients with aggressive non-Hodgkin lymphomas, who are HIV positive. Moreover, PCNSL, usually presents as intraparenchymal supratentorial expansive lesions, while secondary CNS lymphomas tend to present as metastases in the leptomeninges. Although they are more common in immunocompromised patients, their incidence has increased with advancing age. Due to its uniqueness in fi

APA, Harvard, Vancouver, ISO, and other styles

2

Pierce, V., V. Bollavaram, and A. Ali. "Multifactorial Encephalopathy: A Rare Case of Primary Central Nervous System (CNS) Lymphoma With Hypothalamic and Pituitary Involvement." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dantas, Pedro da Cunha, Lucas Pablo Almendro, Ana Caroline Fonseca Silva, and André Douglas Marinho da Silva. "Magnetic resonance and its diagnostic accuracy of glioblastoma: narrative review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.294.

Full text

Abstract:

Introduction: Glioblastoma (GBM) is the most common and lethal Central Nervous System (CNS) malignant cancer, and the exclusion of differential diagnoses - eg primary central nervous system lymphoma (PCNSL) - often occurs via various Magnetic Resonance Imaging (MRI) methodologies. Objective: To describe which best image sequences are critical for greater accuracy in the diagnosis of GBM and for their distinction from other CNS tumors. Methods: This is a literature narrative review, initiated by research in Pubmed database, using associated Key words: “Glioblastoma” and “Magnetic Resonance”; an

APA, Harvard, Vancouver, ISO, and other styles

4

Bruno, Aurélie, Blandine Boisselier, Karim Labreche, et al. "Abstract 5192: Mutational analysis of primary central nervous system lymphoma." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-5192.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bruno, Aurélie, Mailys Daniau, Karima Mokhtari, et al. "Abstract 3896: Recurrent TERT promoter mutations in primary central nervous system lymphoma." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3896.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mantovani, Gabriel Paulo, Rodrigo Fellipe Rodrigues, and Wyllians Vendramini Borelli. "Primary central nervous system angeitis (APSNC) is a vasculitis." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.697.

Full text

Abstract:

Context: Primary central nervous system angeitis (APSNC) is a vasculitis confined to the central nervous system (CNS). Its incidence rate is 2.4 cases per 1,000,000 person-years. It affects predominantly small and medium sized arteries of the cerebral parenchyma, spinal cord and leptomeninges. The most common manifestations are headache, cognitive impairment, stroke and transient ischemic attack. The fact that it results in multifocal inflammation of the arteries and veins can lead to ischemic or hemorrhagic infarctions in multiple vascular territories, more common in the subcortical white mat

APA, Harvard, Vancouver, ISO, and other styles

7

Asya, Tacheva, Chalissery Albi, Beausang Alan, et al. "Intravascular large B-cell lymphoma mimicking primary angiitis of the central nervous system." In Association of British Neurologists: Annual Meeting Abstracts 2023. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jnnp-2023-abn.235.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Matias, Rafael Bragança Rodrigues, Bruna Cardoso de Mattos Boccalini, Renata de Oliveira Costa, and Maria Fernanda Mélega Mingossi. "Mantle Cell Lymphoma recurrence and involvement of the central nervous system after bone marrow transplantation: case report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.215.

Full text

Abstract:

Introduction: Mantle cell lymphoma (MCL) is a subtype of uncommon nonHodgkin lymphoma. The involvement of the central nervous system (CNS) is uncommon in the course of the disease. Objective: To report a case of recurrence of MCL in the CNS as the first manifestation, after chemotherapy and bone marrow transplantation. Case report: Male patient, 49 years old, with no previous comorbidities diagnosed with stage IV MCL (bone marrow), submitted to chemotherapy and autologous transplantation. After two years, he sought out the neurology clinic with a complaint of blurred vision. Neurological exami

APA, Harvard, Vancouver, ISO, and other styles

9

Rogers, Garrett, Noga Lipschitz, Gavriel Kohlberg, Mario Zuccarello, and Ravi Sami. "Primary Central Nervous System Lymphoma of the Internal Auditory Canal Mimicking Facial Nerve Schwannoma." In 29th Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1679739.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sun, Tao, Ekaterina Shatalova, Oliver Braubach, et al. "Abstract 2869: Nano-immuno combination therapy to treat brain primary central nervous system lymphoma." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2869.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Primary Central Nervous System (CNS) Lymphoma"

1

Zhong, Lin, Anqing Lu, Xiyue Lu, et al. Molecular mechanisms and therapeutic prospects of immunotherapy and targeted therapy in primary central nervous system lymphoma. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Li, Yanming, Zhigang Zhao, and Yuanbo Liu. Combined chemotherapy in new diagnosed primary central nervous system lymphoma: a systematic review and network meta‑analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.9.0084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhu, Xiaohui, Shijun Shi, Xiaowei Qiu, and Hong Zheng. Diagnostic performance of 18F-FDG PET/MR for primary central nervous system lymphoma: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.6.0034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mahmoudi, Farhad, Mahtab Mokarram, Sadegh Sabouhi, Sara Hashemi, Parastoo Saberi, and Hadi Zamanian. Application of digital health for improving medication adherence in MS patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0058.

Full text

Abstract:

Review question / Objective: The aim of this study is to evaluate the efficacy of digital health interventions in monitoring and improving medication adherence in Multiple Sclerosis patients. Condition being studied: Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system (CNS), which leads to focal lesions in the white matter, characterized by selective primary demyelination with partial preservation of axons and reactive astrocytic gliosis. The disease is thought to be due to a complex interaction between different genetic and environmental fa

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!